
Caplin Point Laboratories Ltd. (CAPLIPOINT): Caplin Point Laboratories Share Price near 52-week high after 2.29% rise
Updated: 22 Sept 2026 • 10:22 am
Posted by:

Caplin Point Laboratories Share Price is Rs 2,820, up 2.29% from the previous close, and trading close to its 52-week high. The company’s market capitalisation stands at Rs 20,886.87 Cr, placing Caplin Point Laboratories Ltd. (CAPLIPOINT) among the more closely watched names in healthcare stock news today. The latest Univest figures confirm the price event, while the record on hand does not establish a company-specific catalyst. What can be said with confidence is that Caplin Point Laboratories Share Price Today has moved into a near one-year high zone, which keeps Caplin Point Laboratories Stock News relevant for traders and long-term followers tracking the pharma space.
The move matters because the share is now trading only a short distance below its 52-week peak, and the day’s range shows a relatively firm placement near the upper end of intraday trade. For readers searching Caplin Point Laboratories Share Price Update, Caplin Point Laboratories Share Price Live or Caplin Point Laboratories Latest News, the key point is straightforward: the stock is in focus because price, market capitalisation and valuation metrics are all visible in the same snapshot.
Caplin Point Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,820 |
| Previous Close | Rs 2,756.9 |
| Today's Move | +Rs 63.1 (+2.29%) |
| Open | Rs 2,743.7 |
| High | Rs 2,838.9 |
| Low | Rs 2,710 |
| Turnover | Rs 1.43 crore |
| Market Capitalisation | Rs 20,886.87 crore |
Caplin Point Laboratories Ltd. (CAPLIPOINT) traded at Rs 2,820 versus the previous close of Rs 2,756.9, a rise of 2.29%. The stock opened at Rs 2,743.7, reached a high of Rs 2,838.9 and touched a low of Rs 2,710.
Caplin Point Laboratories Share Price Today opened at Rs 2,743.7, moved between Rs 2,710 and Rs 2,838.9, and last traded at Rs 2,820. The stock added Rs 63.1, or 2.29%, versus the previous close of Rs 2,756.9. That places it close to its 52-week high and, based on the gap between the current price and the prior 52-week peak of Rs 2,838.9, the share is trading about 0.67% below that level. Turnover stood at Rs 1.43 Cr during the latest update.
For readers following Caplin Point Laboratories Share News, this is the central factual takeaway: the share price has remained near the upper end of the day’s range and close to its yearly high. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst behind the move. That makes Caplin Point Laboratories Stock News useful primarily as a price-led update rather than a story driven by a disclosed trigger.
What happened today is therefore clear and narrow in scope. Caplin Point Laboratories Share Price Today firmed up from the prior close, stayed above the day’s opening level, and remained close to its 52-week high. For investors scanning Caplin Point Laboratories NSE and Caplin Point Laboratories BSE screens, the session is best understood as a near-peak price event supported by a positive change from the previous close.
Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 20,886.87 crore |
| P/E Ratio | 31.5x |
| P/B Ratio | 5.71x |
| ROE | 20.79% |
| ROCE | 24.97% |
| EPS | Rs 87.53 |
| Book Value Per Share | Rs 483.17 |
| Dividend Yield | 0.29% |
Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P/E 31.5x, P/B 5.71x, ROE 20.79%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.
Caplin Point Laboratories Ltd. has a market capitalisation of Rs 20886.87 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.5x, P/B at 5.71x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 87.53, book value per share of Rs 483.17, dividend yield of 0.29%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.52x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 31.5x |
| Benchmark Median P/E | 28.52x |
| Benchmark Average P/E | 41.89x |
| Benchmark P/E Range | 0x to 747.32x |
| Company P/B Ratio | 5.71x |
| Benchmark Median P/B | 2.96x |
| Company ROE | 20.79% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 24.97% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 20,886.87 crore |
| Benchmark Median Market Cap | Rs 729.99 crore |
Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.5x, which is above the benchmark median of 28.52x, a difference of +10.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 20.79%, which is above the benchmark median of 11.7%, a difference of +77.69%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 24.97%, which is above the benchmark median of 13.61%, a difference of +83.47%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Shilpa Medicare Ltd. | SHILPAMED | 19,966.95 | 70.44 | 7.8 | 9.82 | 11.43 |
| Eris Lifesciences Ltd. | ERIS | 18,310.32 | 27.88 | 4.45 | 19.23 | 14.47 |
| Pfizer Ltd. | PFIZER | 18,304.58 | 25.13 | 4.19 | 17.16 | 23.39 |
| ONESOURCE SPECL PHARMA L | ONESOURCE | 18,295.49 | 0 | 3.14 | -1.26 | 0.44 |
| Granules India Ltd. | GRANULES | 23,868.23 | 36.05 | 4.87 | 14.13 | 15.74 |
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.5x compared with the displayed peer median of 27.88x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.79% compares with a peer median of 14.13% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 20,886.87 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Caplin Point Laboratories
- Caplin Point Laboratories Share Price is Rs 2,820, up 2.29% from the previous close and trading near its 52-week high.
- The gap to the prior 52-week peak of Rs 2,838.9 is about 0.67%, keeping Caplin Point Laboratories Share Price in near-yearly-high territory.
- P/E is 31.5 and P/B is 5.71, which keeps Caplin Point Laboratories Fundamental Analysis focused on valuation.
- ROE at 20.79% and ROCE at 24.97% provide the key profitability context for Caplin Point Laboratories Share Price Today.
- Revenue and net profit both moved higher across the listed quarterly periods, which remains relevant for Caplin Point Laboratories Latest News.
About Caplin Point Laboratories
Caplin Point Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked on NSE and BSE, and its market capitalisation places it among larger listed names in the industry benchmark set. For readers following Caplin Point Laboratories Company News, the core facts here are the company classification, the current price action and the valuation metrics already visible in the latest Univest update.
Caplin Point Laboratories Share Price is therefore being read in the context of a pharmaceutical business with a market cap above the industry median, return ratios above benchmark medians and a valuation that remains important for Caplin Point Laboratories Stock News. This is the cleanest factual description available from the current market snapshot.
Frequently Asked Questions
Why is Caplin Point Laboratories Share Price in the news today?
Ans. Caplin Point Laboratories Share Price is in focus because it is trading near its 52-week high and rose 2.29% to Rs 2,820. The latest Univest data confirms the price event, while no specific catalyst is established.
What is Caplin Point Laboratories Share Price today?
Ans. Caplin Point Laboratories Share Price today is Rs 2,820, compared with the previous close of Rs 2,756.9. The share moved within an intraday range of Rs 2,710 to Rs 2,838.9 during the latest update.
How close is Caplin Point Laboratories Share Price to its 52-week high?
Ans. Caplin Point Laboratories Share Price is about 0.67% below its prior 52-week high of Rs 2,838.9. That keeps the stock in a near yearly high zone for market watchers following Caplin Point Laboratories Stock News.
What does Caplin Point Laboratories Fundamental Analysis show?
Ans. Caplin Point Laboratories Fundamental Analysis shows a P/E of 31.5, P/B of 5.71, ROE of 20.79% and ROCE of 24.97%. EPS is Rs 87.53 and book value per share is Rs 483.17.
Is Caplin Point Laboratories Share Price expensive versus the sector?
Ans. Caplin Point Laboratories Share Price trades on a P/E above the industry median of 28.52 and a P/B above the industry median of 2.96. The stock also has ROE and ROCE above the benchmark medians.
What is the market capitalisation of Caplin Point Laboratories?
Ans. Caplin Point Laboratories Market Cap stands at Rs 20,886.87 Cr. That is well above the same-industry median of Rs 729.99 Cr and above the same-industry average of Rs 14,169.08 Cr.
How have revenue and net profit moved for Caplin Point Laboratories?
Ans. Revenue moved from Rs 5,102.2 in Jun 2025 to Rs 6,103.6 in Jun 2026. Net profit also moved higher over the listed periods, from Rs 1,528 to Rs 1,769.1, based on the latest Univest figures.
Where can I track Caplin Point Laboratories Share Price Live?
Ans. You can track Caplin Point Laboratories Share Price Live on Univest, along with market cap, valuation ratios, 52-week levels and company updates. The platform also groups Caplin Point Laboratories Latest News and sector context in one place.
Track Caplin Point Laboratories Share Price on Univest
Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Caplin Point Laboratories Share Price on Univest for live price updates, company overview, market cap, valuation ratios, earnings metrics, 52-week levels and sector comparison. Univest also helps readers follow Caplin Point Laboratories Share Price Today alongside broader Caplin Point Laboratories Stock Analysis and Caplin Point Laboratories Latest News.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Recent Articles

Tega Industries Share Price Jumps to Fresh 52-Week High at Rs 2,172: Here's Why
22 September 2026

TELGE PROJECTS LIMITED Hits Upper Circuit for the 2nd Straight Session on BSE, 22 September 2026
22 September 2026

Steelcast Ltd. (STEELCAS) Share Price rises 9.29% as stock trades at Rs 346
22 September 2026

Varroc Engineering Share Price Hits Fresh 52-Week High at Rs 910: Key Reasons Behind the Rally
22 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Tega Industries Share Price Jumps to Fresh 52-Week High at Rs 2,172: Here's Why
TELGE PROJECTS LIMITED Hits Upper Circuit for the 2nd Straight Session on BSE, 22 September 2026
Steelcast Ltd. (STEELCAS) Share Price rises 9.29% as stock trades at Rs 346
Varroc Engineering Share Price Hits Fresh 52-Week High at Rs 910: Key Reasons Behind the Rally
SATTVA ENGINEERING CSTN L (SATTVAENGG-SM) Share Price rises 9.49% as stock gains today
Popular this week
PVP Ventures Ltd. Hits Upper Circuit for the 2nd Straight Session on BSE, 22 September 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





